CompletedNot Applicable

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

United States917 participantsStarted 2022-08-04

Plain-language summary

A prospective monitoring study for those individuals treated with Paxlovid

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 * Covid positive * Qualified for Paxlovid prescription (treatment decision already made prior to enrollment) Exclusion Criteria: * Non-english speaking * Resides outside of the United States

What they're measuring

Paxlovid Rebound

Timeframe: 16 day period

Trial details

NCT IDNCT05618600

SponsorScripps Translational Science Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-08

View on ClinicalTrials.gov More COVID-19 trials